Dr. Tjoa has over 25 years of experience in the biotechnology industry, holding leadership positions in research and product development at several biotechnology companies. Read his full bio >>

Antigen-Specific T Cells to GAD65

Antigen-Specific T Cells to GAD65 Our scientists were among the first to develop custom antigen-specific T cells for research use and have created them against a diverse range of targets, including viral, tumor, and self-antigens. We’re now developing the next generation of antigen-specific T cells (both CD4+ and CD8+) to target some of today’s most…

Antigen-Specific T Cells to MUC-1 Antigen

Antigen-Specific T Cells to MUC1 Antigen   Our scientists were among the first to develop custom antigen-specific T cells for research use and have created them against a diverse range of targets, including viral, tumor, and self-antigens. We’re now developing the next generation of antigen-specific T cells to target some of today’s most prevalent and…

Antigen-Specific T Cells Against NY-ESO-1 Antigen

Antigen-Specific T Cells Against NY-ESO-1 Antigen Our scientists were among the first to develop custom antigen-specific T cells for research use and have created them against a diverse range of targets, including viral, tumor, and self-antigens. We’re now developing the next generation of antigen-specific T cells to target some of today’s most prevalent and challenging…

Antigen-Specific T Cells for Melanoma Research: Tyrosinase

Antigen-Specific T Cells for Melanoma Research: Tyrosinase Our scientists were among the first to develop custom antigen-specific T cells for research use and have created them against a diverse range of targets, including viral, tumor, and self-antigens. We’re now developing the next generation of antigen-specific T cells to target some of today’s most prevalent and…

Antigen-Specific T Cells for Melanoma Research: MART-1

Antigen-Specific T Cells for Melanoma Research: MART-1 Our scientists were among the first to develop custom antigen-specific T cells for research use and have created them against a diverse range of targets, including viral, tumor, and self-antigens. We’re now developing the next generation of antigen-specific T cells to target some of today’s most prevalent and…